Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial

PURPOSE: To assess cardiac safety and potential cardiac risk factors associated with trastuzumab in the NCCTG N9831 Intergroup adjuvant breast cancer trial. PATIENTS AND METHODS: Patients with HER2-positive operable early breast cancer were randomized to 1 of 3 treatment arms: doxorubicin plus cyclo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Perez, Edith A., Suman, Vera J., Davidson, Nancy E., Sledge, George W., Kaufman, Peter A., Hudis, Clifford A., Martino, Silvana, Gralow, Julie R., Dakhil, Shaker R., Ingle, James N., Winer, Eric P., Gelmon, Karen A., Gersh, Bernard J., Jaffe, Allan S., Rodeheffer, Richard J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4048960/
https://ncbi.nlm.nih.gov/pubmed/18250349
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.13.5467
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak